Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Start-up | Other Identifier | UAB |
Not provided
Not provided
Insufficient administrative resources.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the current study is to examine the feasibility and effectiveness of acceptance and commitment therapy, a specific form of cognitive-behavioral therapy, for treating general mental health concerns among HIV-positive men.
The purpose of the current study is to examine the feasibility and effectiveness of acceptance and commitment therapy, a specific form of cognitive-behavioral therapy, for treating general mental health concerns among HIV-positive men.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Acceptance and commitment therapy | Experimental | Trial of acceptance and commitment therapy for hiv-positive men. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Acceptance and commitment therapy | Behavioral | Acceptance and commitment therapy is a psychotherapy focused at increasing psychological flexibility and an individual's engagement in valued activities rather than focusing solely or primarily on reducing psychiatric symptoms |
| Measure | Description | Time Frame |
|---|---|---|
| Patient Health Questionnaire-9 Screener | Measure of depressive symptoms | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) |
| PTSD Checklist-5 | Measure of post-traumatic stress symptoms | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) |
| Yale-Brown Obsessive Compulsive Scale | Measure of obsessive-compulsive disorder symptoms | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) |
| Alcohol Use Disorders Identification Test | Measure of alcohol use | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) |
| HIV stigma scale | Measure of facets of stigma experienced by individuals with HIV | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) |
| Internalized homophobia scale | Measure of internalized homophobia | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) |
| Brief pornography screen | Measure of concerning pornography use |
| Measure | Description | Time Frame |
|---|---|---|
| Therapeutic Alliance Scale | Measure of patient and therapist alliance | Administered immediately after final intervention session (8th/final session; each session is 1 hour) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Male
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nicholas Borgogna, PhD | University of Alabama at Birmingham | Principal Investigator |
| Drew Whittington, MS, MA | University of Alabama at Birmingham | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | United States |
Dataset will be shared with requesting researchers
Not provided
When results are published
Requesting researchers
Not provided
Not provided
| ID | Term |
|---|---|
| D001008 | Anxiety Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D064869 | Acceptance and Commitment Therapy |
| ID | Term |
|---|---|
| D015928 | Cognitive Behavioral Therapy |
| D001521 | Behavior Therapy |
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |
Not provided
Not provided
Pre-post design with single group of participants who will each receive the treatment
Not provided
Not provided
Not provided
Not provided
|
| Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) |
| Life Quality Scale | Measure of life quality | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) |
| Experiential Avoidance Rating Scale | Measure of experiential avoidance | Administered at baseline, every two weeks (every second therapy session) during intervention, and immediately after final intervention session (8th/final session; each session is 1 hour) |
| National Institute of Drug Abuse Modified Alcohol, Smoking, and Substance Involvement Screening Test | Measure of drug use | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) |
| High risk sexual behaviors |
| Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) |
| Generalized Anxiety Disorder-7 Screener | Measure of anxiety symptoms | Administered at baseline and immediately after final intervention session (8th/final session; each session is 1 hour) |
| PSYFLEX | Measure of psychological flexibility | Administered at baseline, every two weeks (every second therapy session) during intervention, and immediately after final intervention session (8th/final session; each session is 1 hour) |